Obermatt
See Similar Stocks →

LivaNova

NSQ:LIVN · GB00BYMT0J19
Health Care Equipment & SuppliesMedium

360

76
EV / EBIT60
Price / Owner Earnings15
Owner Earnings Yield46
Dividend Yield1
Price/Sales38
EV / Gross Profit52
Price/Book37
Return on Capital73
Cash Return on Capital48
Return on Equity59
EBIT Margin67
Gross Profitability51
Cash Conversion76
Accruals60
Owner Earnings Margin46
Sales growth79
Profit Growth60
Long-Term EPS Growth72
Reinvestment96
Price momentum86
Debt load73
Refinancing8
Debt Payback100
Liquidity39
Analyst ratings82
Opinion Changes23
Price Target Upside14
Market mood76
Value Creation16/20strong value creator
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

LivaNova generates returns well above its cost of capital, the foundation of durable shareholder value.

Profile

CountryUK
IndustryHealth Care Equipment & Supplies
SizeMedium
TypePublic Company
ExchangeNASDAQGS
Founded2015
Employees2,051
Websitelivanova.com
ISINGB00BYMT0J19
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)S&P MIDCAP (USA)D.J. US Medical Equipment
Themes
CardiovascularBiomedical EngineeringNeuroscienceSleep TechnologyNeurologyCentral Nervous SystemHealth CareMedical Device

Description

LivaNova PLC (LivaNova) operates as a global medical technology company. The company designs, develops, manufactures, markets, and sells products, therapies, and services that align with its mission to create ingenious medical solutions that ignite…

Analysis

Middle-of-the-road

LivaNova PLC sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

On valuation, the picture is expensive. The owner-earnings multiple stands at 61.6×; owner earnings: the cash an owner could take out each year. The implied growth embedded in that price is around 21% a year, against analyst forecasts of 15%. The gap between price and consensus is worth watching: demanding expectations.

Growth is solid; the safety picture is adequate. The company scores 16/20 on our value-creation score: strong value creator.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
81
2023202420252026

All-time high

81

Jun 2026

All-time low

13

Jan 2023

Average rank

42

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
38
57
56
48
Price/Earnings
44
13
1
20
Price/Book
37
71
68
59
Dividend Yield
1
1
1
1
Value (overall)
26
30
27
27

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare LivaNova with its peers
Straumann
VTX:STMN
40
CountrySwitzerland
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
Medtronic
NYQ:MDT
70
CountryIreland
IndustryHealth Care Equipment & Supplies
SizeXX-Large
Full Stock Analysis →
Getinge
STO:GETI B
63
CountrySweden
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
medmix
SWX:MEDX
54
CountrySwitzerland
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Fresenius
GER:FRE
49
CountryGermany
IndustryHealth Care Providers & Services
SizeX-Large
Full Stock Analysis →
Carl Zeiss Meditec
GER:AFX
50
CountryGermany
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →